Skip to content

A study to compare effects of 2 drugs for pain management in patients undergoing lumbar surgery

A Randomised Comparative Study to Compare the Efficacy of Dexmedetomidine Vs Dexamethasone as an Adjuvant with Ropivacaine in Erector Spinae Block in Lumbar Spine Surgery Under General Anaesthesia - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078311
Enrollment
60
Registered
2024-12-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: dexmedetomidine: 0.375% ropivacaine 20ml + 25mcg dexmedetomidine in erector spinae plane block on both sides. It will be given before surgery. Duration of intervention will be approxima

Sponsors

Smt.Bhikiben Kanjibhai Shah Medical Institute and Research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the study, Patients of ASA grade I, II, III of either gender, Patients undergoing elective lumbar surgery, Age of patients 18-75 years.

Exclusion criteria

Exclusion criteria: Patients refusal, Patient belonging to ASA IV, V GRADE, Patients with bleeding and coagulation disorders, Infection at the site.

Design outcomes

Primary

MeasureTime frame
comparing the VAS score, duration of analgesia and total rescue analgesia givenTimepoint: After completion of surgery, then every 2 hourly till 24 hours.

Secondary

MeasureTime frame
comparing hemodynamic parameters, sedation score and complicationsTimepoint: Hemodynamic parameter- every 30 minutes till the completion of surgery, there after every 2 hourly upto 24 hours Sedation score and complications- Every 2 hourly upto 24 hours.

Countries

India

Contacts

Public ContactDr Jigisha Mehta

Smt.Bhikiben Kanjibhai Shah Medical Institute and Research Centre

jbmehta.28@gmail.com8866718168

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026